Companies / Cabaletta Bio, Inc. / Activity
Activity — Cabaletta Bio, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Nichtberger Steven CEO | Buy | Common Stock | $100.8K | +45K +4.56% | 1,031,483 0.61% of shares | medium |
| Jan 21, 2026 | Tomasello Shawn Director | Buy | Common Stock | $50.3K | +23K | 22,725 0.01% of shares | low |
| Jan 21, 2026 | Gavel Steve Executive | Buy | Common Stock | $50.2K | +22K | 22,170 0.01% of shares | low |
| Jan 21, 2026 | Simon Mark Director | Buy | Common Stock | $25.3K | +11K +8.12% | 147,205 0.09% of shares | low |
| Jan 21, 2026 | Binder Gwendolyn Executive | Buy | Common Stock | $24.8K | +11K +56.56% | 31,312 0.02% of shares | low |
| Jan 21, 2026 | Chang David J. Executive | Buy | Common Stock | $19.9K | +9K | 8,800 <0.01% of shares | low |
| Jan 21, 2026 | Gerard Michael Executive | Buy | Common Stock | $15.0K | +7K | 6,600 <0.01% of shares | low |
| Jan 21, 2026 | Bollard Catherine Director | Buy | Common Stock | $10.0K | +4K +440.50% | 5,405 <0.01% of shares | low |